Skip to main content
SpringerLink
Log in

Clinical Trials and Clinical Practice in the Elderly

A Focus on Hypertension

  • Leading Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Altman DG, Dore CJ. Randomization and baseline comparisons in clinical trials. Lancet 335: 149–153, 1990

    Article  PubMed  CAS  Google Scholar 

  • Amery A, Birkenhaeger W, Brixko P, et al. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure and previous cardiovascular disease in patients over the age of 60. Lancet 2: 589–592, 1986

    Article  PubMed  CAS  Google Scholar 

  • Amery A, Birkenhaeger W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1: 1349–1354, 1985

    Article  PubMed  CAS  Google Scholar 

  • Anastos K, Charney P, Charon RA, et al. Hypertension in women: what is really known? Annals of Internal Medicine 115: 287–293, 1991

    PubMed  CAS  Google Scholar 

  • Bailer JC, Mosteller F. Guidelines for statistical reporting in articles for medical journals. Annals of Internal Medicine 108: 266–273, 1988

    Google Scholar 

  • Ball SG. Future approaches to the treatment of hypertension in the light of results from recent trials. Drugs 35(Suppl. 4): 9–15, 1988

    Article  PubMed  Google Scholar 

  • Bateman DN, Chaplin S. Adverse reactions I. British Medical Journal 296: 761, 1988

    Article  PubMed  CAS  Google Scholar 

  • Beck JR. How to evaluate drugs: cost-effectiveness analysis. Journal of the American Medical Association 254: 83–84, 1990

    Article  Google Scholar 

  • Birkenhaeger WH. Choosing the optimum therapy for older hypertensive patients. Drugs & Aging 1: 36–47, 1991

    Article  Google Scholar 

  • Birkenhaeger WH, de Leeuw PW. How far should blood pressure be lowered? Drugs 36: 7–10, 1988

    Article  Google Scholar 

  • Bulpitt CJ, Fletcher AE. Drug treatment and quality of life in the elderly. Clinics in Geriatric Medicine 6: 309–317, 1990

    PubMed  CAS  Google Scholar 

  • Burns R. Cost effectiveness in the treatment of hypertension. Clinics in Geriatric Medicine 5: 829–840, 1989

    PubMed  CAS  Google Scholar 

  • Coope J, Warrender T. Randomised trial of treatment of hypertension in elderly patients in primary care. British Medical Journal 293: 1145–1151, 1986

    Article  PubMed  CAS  Google Scholar 

  • Cruickshank J. Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. British Medical Journal 297: 1227–1230, 1988

    Article  PubMed  CAS  Google Scholar 

  • Curb JD, Borhani NO, Schnaper H, et al. Detection and treatment of hypertension in older individuals. American Journal of Epidemiology 121: 371–376, 1985

    Article  PubMed  CAS  Google Scholar 

  • Cutler JA, MacMahon SW, Furberg CD. Controlled clinical trials of drug treatment of hypertension: a review. Hypertension 13(Suppl. 1): 36–44, 1989

    Article  Google Scholar 

  • Davidson RA, Caranasos GJ. Should the elderly hypertensive be treated? Evidence from clinical trials. Archives of Internal Medicine 147: 1933–1937, 1987

    Article  PubMed  CAS  Google Scholar 

  • Denig P, Haaijer-Ruskamp FM, Zijsling DH. How physicans choose drugs. Social Science and Medicine 21: 1381–1386, 1988

    Google Scholar 

  • Department of Clinical Epidemiology and Biostatistics, Mc-Master University Health Sciences Centre. How to read clinical journals. V. To distinguish useful from useless or even harmful therapy. Canadian Medical Association Journal 124: 1156–1162, 1981

    Google Scholar 

  • Deyo RA. The quality of life, research and care. Annals of Internal Medicine 114: 695–696, 1991

    PubMed  CAS  Google Scholar 

  • Editorial. Guidelines for writing papers. British Medical Journal 296: 48–50, 1988

  • Edmonds D, Greminger P, Vetter W, et al. The neglected time factor and antihypertensive therapy. Postgraduate Medicine 83 (Spec. No.): 40–45, 1988

    Google Scholar 

  • European Working Party on High Blood Pressure in the Elderly (EWPHE). Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly. Lancet 1: 1349–1354, 1985b

    Google Scholar 

  • European Working Party on High Blood Pressure in the Elderly (EWPHE). An International Trial of Antihypertensive Therapy of Elderly Patients: objectives, protocol and organization. American Journal of Medicine 90(Suppl. 3A): 300–334, 1985a

    Google Scholar 

  • Farnett L, Mulrow CD, Linn WD, et al: The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? Journal of the American Medical Association 265: 489–495, 1991

    Article  PubMed  CAS  Google Scholar 

  • Food and Drug Administration. Proposed guidelines for the clinical evaluation of antihypertensive drugs. Food and Drug Administration, Division of Cardio-Renal Products, Rockville, 1989b

    Google Scholar 

  • Food and Drug Administration. US Department of Health and Human Services, Guidelines for the study of drugs likely to be used in the elderly. Center for Drug Evaluation and Research, Rockville, 1989a

    Google Scholar 

  • Freiman JA, Chalmer TC, Smith H, et al. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. New England Journal of Medicine 299: 690–694, 1978

    Article  PubMed  CAS  Google Scholar 

  • Furberg CD, Black DM. The systolic hypertension in the elderly pilot program: methodological issues. European Heart Journal 9: 223–227, 1988

    PubMed  CAS  Google Scholar 

  • Gardner MJ, Altman DG. Estimating with confidence. British Medical Journal 296: 1210–1211, 1988

    Article  PubMed  CAS  Google Scholar 

  • Gardner MJ, Machin D, Campbell MJ. Use of check lists in assessing the statistical content of medical studies. British Medical Journal 292: 810–812, 1986

    Article  PubMed  CAS  Google Scholar 

  • Gifford RH, Feinstein AR. A critique of methodology in studies of anticoagulant therapy for myocardial infarction. New England Journal of Medicine 280: 351–357, 1969

    Article  PubMed  CAS  Google Scholar 

  • Gurland BJ, Teresi J, McFate Smith W, et al. Effects of treatment for isolated hypertension on cognitive status and depression in the elderly. Journal of the American Geriatric Society 36: 1015–1022, 1988

    CAS  Google Scholar 

  • Hypertension Detection and Follow-up Program (HDFP) Cooperative Group. Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. Journal of the American Medical Association 259: 2113–2122, 1988

    Article  Google Scholar 

  • Hypertension Detection and Follow-up Program (HDFP) Cooperative Group. Five year findings of the Hypertension Detection and Follow-up Program. II. Mortality by race, sex and age. Journal of the American Medical Association 242: 2572–2577, 1979

    Article  Google Scholar 

  • Irey NS. Diagnostic problems in drug-induced diseases. In Meyler L, Peck HM (Eds) Drug-induced diseases, Vol. 4, pp. 5–24, Excerpta Medica, Amsterdam, 1972

    Google Scholar 

  • Julius S, Jamerson K, Mehia A, et al. The association of borderline hypertension with target organ changes and higher coronary risk. Journal of the American Medical Association 264: 364–358, 1990

    Article  Google Scholar 

  • Kitler ME. Clinical trials in the elderly: pivotal points. Clinics in Geriatric Medicine 6: 235–255, 1990a

    PubMed  CAS  Google Scholar 

  • Kitler ME. Dose-response relationship focus: the elderly. In Kuhlman J & Wingender W (Eds) Dose-response relationship of drugs, pp. 27–32, W. Zuckschwerdt Verlag, San Francisco, 1990b

    Google Scholar 

  • Kitler ME. The changing face of clinical trials. Journal of Hypertension 6(Suppl. 1): 73–80, 1988

    Google Scholar 

  • Kitler ME. The elderly in clinical trials: regulatory concerns. Drug Information Journal 23: 123–137, 1989

    Google Scholar 

  • Kitler ME, Armitage P, (Eds) Clinical trials: a practical tool in cardiology. European Heart Journal 9: 203–234, 1988

    Google Scholar 

  • Kitler ME. Clinical trials in hypertension: the present and perspectives for the future. Journal of Hypertension 8(Suppl. 4): 53–59, 1990c

    Google Scholar 

  • Lamy PP. Adverse drug effects. Clinics in Geriatric Medicine 6: 293–307, 1990

    PubMed  CAS  Google Scholar 

  • Langer RD, Ganiats TG, Barrett-Connor E. Paradoxial survival of elderly men with high blood pressure. British Medical Journal 209: 1356–1357, 1989

    Article  Google Scholar 

  • Levy RI. The decline in cardiovascular disease mortality. Annual Review of Public Health 2: 49–70, 1981

    Article  PubMed  CAS  Google Scholar 

  • Lionel NDM, Herxheimer A. Assessing reports of therapeutic trials. British Medical Journal 3: 637–640, 1970

    Article  PubMed  CAS  Google Scholar 

  • Lipsitz LA. Altered blood pressure homeostasis in advanced age: clinical and research implications. Journal of Gerontology 44: 179–183, 1989

    Google Scholar 

  • Lyles MF. Adverse effects of antihypertensive therapy. Clinics in Geriatric Medicine 5: 691–702, 1989

    PubMed  CAS  Google Scholar 

  • MacMahon SW, Jeffrey AC, Furberg CD, et al. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Progress in Cardiovascular Diseases 24: 99–118, 1986

    Article  Google Scholar 

  • MacMahon S, Cutler J, Stamler J. Antihypertensive drug treatment: potential, expected and observed effects on stroke and coronary artery disease. Hypertension 13(Suppl. 5): 145–150, 1989

    Google Scholar 

  • Management Committee. Treatment of mild hypertension in the elderly: a study initiated and administered by the National Heart Foundation of Australia. Medical Journal of Australia 2: 398–402, 1981

    Google Scholar 

  • Matilla K, Haavisto M, Rajala S, et al. Blood pressure and five year survival in the very old. British Medical Journal 296: 887–889, 1988

    Article  Google Scholar 

  • Maxwell MH, Ford CE. Cardiovascular mortality and morbidity in HDFP patients 50–69 years old at entry. Journal of Cardiovascular Pharmacology 7(Suppl. 2): S6–S9, 1985

    Google Scholar 

  • Medical Research Council (MRC) Working Party. MRC trial of mild hypertension: principle results. British Medical Journal 291: 197–204, 1985

    Article  Google Scholar 

  • Messerli FH, Ventura HO, Glade LB, et al. Essential hypertension in the elderly: hemodynamics, antravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet 2: 983–985, 1983

    Article  PubMed  CAS  Google Scholar 

  • Michel DJ, Knodel LC. Comparison of three algorithms used to evaluate adverse drug reactions. American Journal of Hospital Pharmacy 43: 1709–1714, 1986

    PubMed  CAS  Google Scholar 

  • Multiple Risk Factor Research Trial (MRFIT) Intervention Group. Mortality after 10½ years for hypertension participants in the Multiple Risk Factor Intervention Group. Circulation 82: 1616–1628, 1990

    Article  Google Scholar 

  • Ray WA, Schaffner W, Oates JA. Therapeutic choice in the treatment of hypertension. American Journal of Medicine (Suppl. 6C): 9–16, 1986

    Google Scholar 

  • Reidenberg MM: The quality of clinical research. Clinical Pharmacology and Therapeutics 47: 669–670, 1990

    Article  Google Scholar 

  • Rose M, McMahan FG. Some problems with antihypertensive drug studies in the context of new guidelines. American Journal of Hypertension 3: 151–155, 1990

    PubMed  CAS  Google Scholar 

  • SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the ElderlyProgram (SHEP). Journal of the American Medical Association 265: 3255–3264, 1991

    Article  Google Scholar 

  • Simon R. Confidence intervals for reporting results of clinical trials. Annals of Internal Medicine 105: 429–435, 1986

    PubMed  CAS  Google Scholar 

  • Spilker B. Patient refusers, nonqualifiers, dropouts, dropins and discontinuers. Drug News Perspectives 3(1): 14–18, 1990

    Google Scholar 

  • Staessen J, Bulpitt C, Clement D, et al. Relation between mortality and blood pressure in elderly patients with hypertension. British Medical Journal 289: 1552–1556, 1989

    Article  Google Scholar 

  • Stern MF. The recent decline in ischemic heart disease mortality. Annals of Internal Medicine 91: 630–640, 1979

    PubMed  CAS  Google Scholar 

  • Sulkava R, Erkinjuntti T. Vascular dementia due to cardiac arrhythmias systemic hypotension. Acta Neurologica Scandinavica 76: 123–127, 1987

    Article  PubMed  CAS  Google Scholar 

  • Tyson JE, Furzan JA, Reisch JS, et al. An evaluation of the quality of therapeutic studies in perinatal medicine. Journal of Pediatrics 102: 10–13, 1983

    Article  PubMed  CAS  Google Scholar 

  • Vagelos PR. Are prescription drug prices high? Science 252: 11080–1084, 1991

    Article  Google Scholar 

  • Weiler PG. Assessing the impact of antihypertensive therapy on quality of life in the elderly. Clinics in Geriatric Medicine 5: 703–716, 1989

    PubMed  CAS  Google Scholar 

  • Weinstein MC, Stason WB. Allocation of resources to manage hypertension. New England Journal of Medicine 296: 732–739, 1977

    Article  PubMed  Google Scholar 

  • Wessely S, Nickson J, Cox B. Symptoms of low blood pressure: a population study. British Medical Journal 301: 362–365, 1990

    Article  PubMed  CAS  Google Scholar 

  • Winker MA, Murphy MB. Isolated systolic hypertension in the elderly. Journal of the American Medical Association 265: 3301–3302, 1991

    Article  PubMed  CAS  Google Scholar 

  • Wright Jr JT. Geriatric hypertension therapy: a guide to cost-effectiveness. Geriatrics 43: 55–62, 1988

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Maison des Truites, CH-1182, Gilly, Switzerland

    Mary Ellen Kitler

Authors
  1. Mary Ellen Kitler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kitler, M.E. Clinical Trials and Clinical Practice in the Elderly. Drugs & Aging 2, 86–94 (1992). https://doi.org/10.2165/00002512-199202020-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002512-199202020-00002

Search

Navigation